Reduction in oral corticosteroid use in patients receiving omalizumab for allergic asthma in the real-world setting

BACKGROUND: Oral corticosteroids (OCS) are commonly administered in patients with severe persistent allergic asthma. Despite their efficacy, they are associated with a wide variety of adverse events. The eXpeRience registry was set up to investigate real-world outcomes among patients receiving omali...

Descripción completa

Detalles Bibliográficos
Autores principales: Braunstahl, Gert-Jan, Chlumský, Jan, Peachey, Guy, Chen, Chien-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3879326/
https://www.ncbi.nlm.nih.gov/pubmed/24305549
http://dx.doi.org/10.1186/1710-1492-9-47

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3879326/
https://www.ncbi.nlm.nih.gov/pubmed/24305549
http://dx.doi.org/10.1186/1710-1492-9-47

Ejemplares similares